NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/02/2023
Back to search
Official data from USPTO
DERMAN ANTIFUNGAL CREAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
05/02/2023
Trademark type
Combined
Nice classes
5
Filing date
03/23/2012
Registration date
11/27/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2023
Last transaction
05/02/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/02/1995
First use in commerce
01/10/1997
Drawing code
3
Owner type
03
Owner location
Ciudad De Mexico, MX
Examiner
MARCY, AMY ALFIERI
Law office
L90
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the word "DERMAN" written in white letters against a brown rectangle. The words "antifungal cream" in white letters and smaller font, are drawn against an orange rectangle immediately beneath the brown rectangle. This is all drawn against yellow grid crisscrossed by white lines. A pair of feet, drawn in orange with a white outline, appears on the right side of the drawing. The right foot extends from the lower right of the yellow background across the orange rectangle and partially into the brown rectangle.
Holders and representatives
Holders
Compania Internacional de Comercio S.A.P.I. de C.V.
Compania Internacional de Comercio S.A.P.I. de C.V.
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
preparations for medical useanti-fungal creams
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/02/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/02/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/02/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
10/17/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/27/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/30/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/30/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/30/2018
E815
TEAS SECTION 8 & 15 RECEIVED
04/19/2018
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
03/09/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/09/2018
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
03/07/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/06/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/27/2017
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
08/07/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/07/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/03/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/27/2012
PUBO
PUBLISHED FOR OPPOSITION
09/11/2012
NPUB
NOTICE OF PUBLICATION
08/22/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/06/2012
ALIE
ASSIGNED TO LIE
08/05/2012
CNEA
EXAMINERS AMENDMENT MAILED
07/19/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
07/19/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/19/2012
CNRT
NON-FINAL ACTION MAILED
07/06/2012
CNRT
NON-FINAL ACTION WRITTEN
07/06/2012
DOCK
ASSIGNED TO EXAMINER
06/28/2012
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
03/31/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/30/2012
NWAP
NEW APPLICATION ENTERED
03/27/2012
Continuous trademark protection
Get notified about every new filing that threatens DERMAN ANTIFUNGAL CREAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.